Federal contract award
75N92025F00166
[25-013766] IN-VIVO GENE THERAPY CORE REQUIRES DIGITAL DROPLET PCR IN ORDER TO PERFORMING PCR ON LOW ABUNDANCE TARGETS, TARGETS IN COMPLEX BACKGROUNDS, ALLELIC VARIANTS (SNPS) AND FOR MONITORING OF SUBTLE CHANGES IN TARGET LEVELS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | 47QSMS25D00A9 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $137.9K |
| Current contract value | $137.9K |
| Potential contract value / ceiling | $137.9K |
| Start date | Aug 22, 2025 |
| Current end date | Nov 22, 2025 |
| Potential end date | Nov 22, 2025 |
| Latest award activity | Aug 26, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 26, 2025 | 0 | $137.9K | [25-013766] IN-VIVO GENE THERAPY CORE REQUIRES DIGITAL DROPLET PCR IN ORDER TO PERFORMING PCR ON LOW ABUNDANCE TARGETS, TARGETS IN COMPLEX BACKGROUNDS, ALLELIC VARIANTS (SNPS) AND FOR MONITORING OF SUBTLE CHANGES IN TARGET LEVELS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.